Journal List > Intest Res > v.18(3) > 1516081549

TOOLS
Yagisawa, Kobayashi, Ozaki, Okabayashi, Toyonaga, Miura, Hayashida, Saito, Nakano, Matsubara, Hisamatsu, and Hibi: Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
CORRIGENDUM

Intest Res 2020;18(3):343-344.

Published online: 20 July 2020

DOI: https://doi.org/10.5217/ir.2018.00078-c1

Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

Keiji Yagisawa1, Taku Kobayashi2, Ryo Ozaki2, Shinji Okabayashi2, Takahiko Toyonaga2, Miki Miura3, Mari Hayashida3, Eiko Saito2, Masaru Nakano2, Hajime Matsubara1, Tadakazu Hisamatsu3, Toshifumi Hibi2

1Department of Pharmacy and Kitasato University Kitasato Institute Hospital, Tokyo, Japan

2Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan

3The Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan

© Copyright 2020. Korean Association for the Study of Intestinal Diseases. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Intest Res 2019;17(1):87-93
In the version of this article initially published, Figure 2 contains errors in the content of the questionnaire.
On page 89, the figure should be corrected as following.
From:
To:

Fig. 2.
(A) Questionnaire 1: acceptability of tablets. (B) Questionnaire 2: acceptability of granules. (C) Questionnaire 3: comparison of tablets and granules. All the original questionnaires were written in Japanese. CR, controlled-release.
ir-2018-00078-c1f1.tif
Fig. 2.
(A) Questionnaire 1: acceptability of tablets. (B) Questionnaire 2: acceptability of granules. (C) Questionnaire 3: comparison of tablets and granules. All the original questionnaires were written in Japanese. CR, controlled-release.
ir-2018-00078-c1f2.tif
TOOLS
Similar articles